|
CEP55 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.70639999999E-05 |
| Normal-vs-Stage2 |
3.212200E-02 |
| Normal-vs-Stage3 |
5.81179999999959E-05 |
| Normal-vs-Stage4 |
3.820500E-03 |
| Stage1-vs-Stage2 |
5.235400E-01 |
| Stage1-vs-Stage3 |
5.815400E-04 |
| Stage1-vs-Stage4 |
5.463300E-03 |
| Stage2-vs-Stage3 |
8.607800E-02 |
| Stage2-vs-Stage4 |
7.705700E-02 |
| Stage3-vs-Stage4 |
7.597400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.66131561232896E-12 |
| Normal-vs-AfricanAmerican |
4.02130000000112E-05 |
| Normal-vs-Asian |
2.042000E-02 |
| Caucasian-vs-AfricanAmerican |
5.773200E-01 |
| Caucasian-vs-Asian |
4.021000E-01 |
| AfricanAmerican-vs-Asian |
2.173400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62481139653892E-12 |
| Normal-vs-Female |
1.84262999999296E-05 |
| Male-vs-Female |
3.194000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.13549999999297E-05 |
| Normal-vs-Extreme_Weight |
2.96439983671348E-10 |
| Normal-vs-Obese |
1.22319999995568E-06 |
| Normal-vs-Extreme_Obese |
6.21119999988373E-07 |
| Normal_Weight-vs-Extreme_Weight |
1.137960E-01 |
| Normal_Weight-vs-Obese |
8.275000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.903000E-03 |
| Extreme_Weight-vs-Obese |
4.404300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.104800E-03 |
| Obese-vs-Extreme_Obese |
5.552300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.036000E-03 |
| Normal-vs-Age(41-60Yrs) |
4.78872497211569E-12 |
| Normal-vs-Age(61-80Yrs) |
4.71339999996712E-06 |
| Normal-vs-Age(81-100Yrs) |
7.181400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.146100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.157400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.356440E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.676400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.097700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.462400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.44169137633799E-14 |
| Normal-VS-Type2 PRCC |
9.62760005052132E-09 |
| Normal-VS-KIRP CIMP |
6.362200E-04 |
| Normal-VS-Unclassified PRCC |
5.53549999999792E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.539800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.478460E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.008000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.482800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.834200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.143000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.6390999999989E-05 |
| Normal-vs-N1 |
2.11599999999645E-06 |
| Normal-vs-N2 |
1.211800E-01 |
| N0-vs-N1 |
3.190100E-04 |
| N0-vs-N2 |
4.318000E-02 |
| N1-vs-N2 |
5.907200E-01 |
|
|
